Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
This traceability is required under FDA drug serialization regulations and is a core part of Hospira's quality system
This therapy is provided for research purposes only under physician supervision
Improved Insulin Sensitivity : Theres evidence to suggest that GIP receptor activation can improve insulin sensitivity in peripheral tissues, such as muscle and fat, helping the body to use insulin more effectively
Potential Reactions: Some patients may experience mild or temporary effects such as injection site irritation, fatigue, nausea, headaches, or other unexpected symptoms
Bioavailability: Due to its shorter sequence, BPC 159 may have different absorption and distribution patterns in the body compared to BPC 157
US$ 28.01
US$ 24.95
US$ 28.99
